174
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Terpenoids from the tuber of Cremastra appendiculata

, , , &
Pages 677-683 | Received 09 May 2007, Accepted 29 Jun 2007, Published online: 17 Jul 2008
 

Abstract

Two new terpenoids including a cadinane sesquiterpene (1), and an ent-kaurane diterpene diglycoside (2), together with a known triterpene containing 32 carbons (3), have been isolated from the ethanolic extract of Cremastra appendiculata. Their structures were established by the spectroscopic methods including the IR, MS, 1D-, and 2D-NMR experiments as ( − )-cadin-4,10(15)-dien-11-oic acid (1), ( − )-ent-12β-hydroxykaur-16-en-19-oic acid, 19-O-β-d-xylopyranosyl-(1 → 6)-O-β-d-glucopyranoside (2), and (+)-24,24-dimethyl-25,32-cyclo-5α-lanosta-9(11)-en-3β-ol (3). Compounds 1–3 were evaluated against several human cancer cell lines. Compound 3 showed in vitro-selective cytotoxicity against human breast cancer cell lines (MCF-7) with an IC50 of 3.18 μM, but 1 and 2 were inactive (IC50>10 μg/ml).

Acknowledgements

Financial support is from the New Century Excellent Talent supporting program of the Chinese Ministry of Education (NCET), the NSF (Grant no. 20372084 and 20432030), and the national ‘973’ program of China (Grant no. 2004CB13518906), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, Grant no. IRT0514).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.